{"doi":"10.1016/j.canlet.2009.07.010","title":"Geldanamycin and its anti-cancer activities","abstract":null,"journal":"Cancer Letters","year":2010,"id":22979,"datarank":8.257360476483461,"base_score":5.117993812416755,"endowment":5.117993812416755,"self_citation_contribution":0.7676990718625134,"citation_network_contribution":7.489661404620947,"self_endowment_contribution":0.7676990718625134,"citer_contribution":7.489661404620947,"corpus_percentile":null,"corpus_rank":null,"citation_count":166,"citer_count":166,"citers_with_citation_signal":148,"citers_with_endowment":148,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":142719,"name":"Clayton R. Hunt","orcid":null,"position":1,"is_corresponding":false},{"id":142720,"name":"Nobuo Horikoshi","orcid":null,"position":2,"is_corresponding":false},{"id":141465,"name":"Yayoi Fukuyo","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.117993812416755,"endowment":5.117993812416755,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19850405","pmcid":null,"openalex_id":"https://openalex.org/W2023261559","authors":[],"funders":[{"funder_name":"NCI NIH HHS","grant_id":"R01CA98666","title":null}],"total_grants":1,"fwci":4.8309,"citation_percentile":0.95867247,"influential_citations":5,"citation_trend":[{"year":2012,"count":19},{"year":2013,"count":12},{"year":2014,"count":12},{"year":2015,"count":12},{"year":2016,"count":11},{"year":2017,"count":7},{"year":2018,"count":4},{"year":2019,"count":13},{"year":2020,"count":9},{"year":2021,"count":9},{"year":2022,"count":9},{"year":2023,"count":17},{"year":2024,"count":9},{"year":2025,"count":6}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0304383509004996?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0304383509004996?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.canlet.2009.07.010","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/19850405","host_type":"repository"}],"fields_of_study":["Heat shock proteins research","Enzyme Structure and Function","Medicine","Biology","Animals","Antineoplastic Agents","Benzoquinones","HSP90 Heat-Shock Proteins","Humans","Lactams, Macrocyclic","Neoplasms","Signal Transduction"],"mesh_terms":["Animals","Antineoplastic Agents","Humans","Neoplasms","Signal Transduction","Benzoquinones","HSP90 Heat-Shock Proteins","Lactams, Macrocyclic"],"keywords":["Geldanamycin","Hsp90","CDC37","Carcinogenesis","Cancer research","Hsp90 inhibitor","Biology","Chaperone (clinical)","Oncogene","MAPK/ERK pathway","Cancer","Heat shock protein","Kinase","Cell biology","Cell cycle","Genetics","Medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-07T17:22:59.663927Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}